secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001683168-22-004180
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences receives Nasdaq minimum bid price deficiency notice
-----------------------------------------------------------------------

- Nasdaq notified Xenetic on June 3, 2022 that its common stock bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until November 30, 2022) to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- To cure, closing bid price must be at least $1.00 for a minimum of ten consecutive business days before the Compliance Date.
- If not cured by Nov 30, Xenetic may be eligible for a second 180-day period if it meets other listing standards and notifies Nasdaq of intention to cure, possibly via reverse stock split.
- There is no assurance the company will regain compliance; risk of delisting if deficiency is not addressed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822004180/0001683168-22-004180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822004180/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-004180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer